NCT03335514View on ClinicalTrials.gov

GALNT4 in Patients With Acute Coronary Syndrome

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions

Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

expression of GALNT4

Blood is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture and the total RNA was extracted from blood.Realtime PCR was performed to measure the expression of GALNT4.

Trial Locations (1)

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

All Listed Sponsors

lead

The First Affiliated Hospital of Dalian Medical University

OTHER

NCT03335514 - GALNT4 in Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter